These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4528545)

  • 21. The effect of high doses of poly(I).poly(C) induced mouse L cell interferon on Rauscher leukemia virus induced erythroleukemia in BALB/c mice.
    Hekman RA; Prins ME; Bosveld IJ; Trapman J
    Int J Cancer; 1981; 27(4):493-500. PubMed ID: 6168593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Toxoplasma on manifestations of Moloney virus infections.
    McLeod R; Estes RG; Cohen H
    Trans R Soc Trop Med Hyg; 1985; 79(6):781-7. PubMed ID: 2938310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the DNA polymerase of Rauscher leukemia virus by single-stranded polyribonucleotides.
    Tuominen FW; Kenney FT
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2198-202. PubMed ID: 5289379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex.
    Fischinger PJ; Moore CO; O'Connor TE
    J Natl Cancer Inst; 1969 Apr; 42(4):605-22. PubMed ID: 5775808
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of the immune system by synthetic polynucleotides. II. Action on peritoneal exudate cells.
    Johnson HG; Johnson AG
    J Exp Med; 1971 Mar; 133(3):649-64. PubMed ID: 4106807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
    Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA; Perk K; Turner W; Burka B; Gomez M
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcomas in chickens and Rauscher leukemia in mice.
    Svec P; Béderová E; Svec J
    Neoplasma; 1975; 22(5):519-24. PubMed ID: 1196434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
    Turner W; Chirigos MA
    Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory effect of interferon on murine sarcoma and leukaemia virus infection in vitro.
    Sarma PS; Shiu G; Baron S; Huebner RJ
    Nature; 1969 Aug; 223(5208):845-6. PubMed ID: 4307970
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of interferon in the protective effect of the double-stranded polyribonucleotide against murine tumors induced by Moloney sarcoma virus.
    De Clercq E; De Somer P
    J Natl Cancer Inst; 1971 Dec; 47(6):1345-55. PubMed ID: 5120413
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of Harvey murine sarcoma virus complex.
    Harvey JJ
    Bibl Haematol; 1970; (36):240-5. PubMed ID: 4376364
    [No Abstract]   [Full Text] [Related]  

  • 39. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
    Hanna MG; Ihle JN; Lee JC
    Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.